Drug Type Small molecule drug |
Synonyms CP 122288, CP-122,288 |
Action agonists |
Mechanism 5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H23N3O2S |
InChIKeyBWQZTHPHLITOOZ-CQSZACIVSA-N |
CAS Registry143321-74-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Migraine Disorders | Phase 2 | United States | - | |
| Migraine Disorders | Phase 2 | United Kingdom | - |





